D
Amylyx Pharmaceuticals, Inc. AMLX
$3.63 -$0.045-1.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -100.61% -99.59% -101.04% 24.10% 395.54%
Total Other Revenue -- -- -- -- --
Total Revenue -100.61% -99.59% -101.04% 24.10% 395.54%
Cost of Revenue -124.53% 65.22% -11.15% 419.13% 111.73%
Gross Profit -76.66% -185.76% -149.99% -253.44% 1,545.05%
SG&A Expenses -67.27% -63.41% -50.11% 31.25% 27.90%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -62.46% -9.40% -3.53% 186.84% 60.23%
Operating Income -2,202.07% -504.17% -477.63% -5,848.86% 104.34%
Income Before Tax -689.58% -424.41% -402.83% -8,549.82% 115.37%
Income Tax Expenses -136.39% -- -- 242.35% 201.38%
Earnings from Continuing Operations -893.62% -447.98% -429.35% -7,652.00% 111.08%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -893.62% -447.98% -429.35% -7,652.00% 111.08%
EBIT -2,202.07% -504.17% -477.63% -5,848.86% 104.34%
EBITDA -1,911.81% -496.59% -471.44% -6,488.16% 105.03%
EPS Basic -879.77% -444.53% -425.53% -7,518.22% 110.75%
Normalized Basic EPS -1,263.55% -421.13% -399.28% -8,435.88% 92.40%
EPS Diluted -888.76% -456.67% -445.16% -8,853.50% 110.62%
Normalized Diluted EPS -1,298.40% -432.32% -412.30% -8,906.45% 92.58%
Average Basic Shares Outstanding 1.75% 1.00% 1.18% 1.70% 3.05%
Average Diluted Shares Outstanding -0.87% -2.38% -3.00% -4.25% 5.78%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings